Skip to Content Facebook Feature Image

Medicilon and Hengrui Pharma Deepen Strategic Collaboration to Support Innovation in ADCs, Small Nucleic Acids, and CGT Drugs

Business

Medicilon and Hengrui Pharma Deepen Strategic Collaboration to Support Innovation in ADCs, Small Nucleic Acids, and CGT Drugs
Business

Business

Medicilon and Hengrui Pharma Deepen Strategic Collaboration to Support Innovation in ADCs, Small Nucleic Acids, and CGT Drugs

2024-07-31 22:39 Last Updated At:22:55

BOSTON, July 31, 2024 /PRNewswire/ -- Recently, Shanghai Medicilon Inc. ("Medicilon") and Jiangsu Hengrui Pharmaceuticals Co., Ltd. ("Hengrui Pharma") reached a strategic collaboration agreement. The cooperative efforts will focus on preclinical evaluation of new drug modalities, particularly ADCs, small nucleic acids, and CGT (cell and gene therapy) drugs. The goal of this partnership is to advance the innovation of the Chinese pharmaceutical industry to compete on an international level.

The elevated commitment to collaboration between Medicilon and Hengrui Pharma builds upon the solid foundation from years of experience and well-established trust. The organizations plan to integrate Medicilon's preclinical R&D expertise with Hengrui Pharma's innovative strategies and market influence. Medicilon will leverage its technological advantages in drug discovery and development to provide Hengrui Pharma with a range of preclinical services, focusing on efficacy testing, pharmacokinetics, and toxicology studies for new drug modalities. Medicilon and Hengrui Pharma will combine efforts to generate breakthroughs in pharmaceutical therapies.

The atmosphere of the exchange was enthusiastic and congenial. Hengrui Pharma's Vice General Manager & Global R&D President Lianshan Zhang, along with other executives, visited Medicilon's Pudong Chuansha Park. They were welcomed by Medicilon's CEO Chunlin Chen and key team members.

During the visit, Medicilon's R&D Team introduced their one-stop preclinical services platform for pharmaceutical R&D. They highlighted the Medicilon's capabilities and technical strengths in safety evaluation, pharmacology, and pharmacokinetics, with special attention to PROTAC, ADC, nucleic acids, bispecific antibodies, peptides, vaccines, and CGT. 

Hengrui Pharma's Vice General Manager & Global R&D President Lianshan Zhang stated, "Medicilon possesses robust innovation capabilities and service quality in this field, making it a trusted CRO partner. The collaboration between Hengrui Pharma and Medicilon not only acknowledges past achievements but also represents a deep exploration of future collaboration potential and forward-looking strategic planning." 

Medicilon's Founder & CEO Chunlin Chen stated, "Medicilon and Hengrui Pharma firmly believe that, through close collaboration, the process of drug R&D will be accelerated in the future, contributing to the innovative development of the global pharmaceutical industry."

Website: https://www.medicilon.com/ 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Medicilon and Hengrui Pharma Deepen Strategic Collaboration to Support Innovation in ADCs, Small Nucleic Acids, and CGT Drugs

Medicilon and Hengrui Pharma Deepen Strategic Collaboration to Support Innovation in ADCs, Small Nucleic Acids, and CGT Drugs

PolicyStreet gives back to Malaysians who supported their growth by offering FREE road tax to all Proton and Perodua car owners renewing their car insurance.

KUALA LUMPUR, Malaysia, Sept. 9, 2024 /PRNewswire/ -- "Berkereta jenama negara, megah menyusur di jalan raya"— an iconic lyric that resonates with every Malaysian, evoking national pride with every rendition. This Malaysia Day, PolicyStreet turns that pride into a tangible benefit. PolicyStreet continues its Betul-Betul FREE Road Tax campaign, offering all Malaysians driving national cars FREE road tax when renewing their car insurance on 12 and 13 September.

The Betul-Betul FREE Road Tax campaign showcases PolicyStreet's gratitude to Malaysians who have supported its journey from humble beginnings to becoming a leading insurtech in the nation. Malaysians' support has been crucial in embracing "alam cyber teknologi terkini" and enabling companies like PolicyStreet to thrive.

"'Keranamu kami mendakap tuah'— Without the support of Malaysians, PolicyStreet would not have achieved the successes it enjoys today. Beyond our embedded insurance solutions serving the underserved, PolicyStreet is committed to giving back to the community and improving financial resilience in the region, says Yen Ming Lee, Co-founder and Group Chief Executive Officer of PolicyStreet. 

Building on the success of the Betul-Betul FREE Road Tax campaign launched in conjunction with Merdeka Day, Malaysians can once again benefit from free road tax by visiting PolicyStreet's car insurance renewal portal at car.policystreet.com. Users can simply select the road tax renewal add-on at checkout, no promo code needed.

Held from 28 to 29 August, the first Betul-Betul Free Road Tax campaign offered Malaysians free road tax in conjunction with Merdeka Day, no strings attached. The campaign saw close to 10,000 car insurance quotes generated, reflecting the strong community support for PolicyStreet's initiatives.

Looking ahead, PolicyStreet remains dedicated to enhancing its insurance solutions and services for underserved communities. As part of this commitment, the company pledges to offer the 'Cheapest Road tax in Town', offering up to 70% discounts on road tax for every car insurance renewal. The bold promise, available from 14 September onwards, ensures that all Malaysians benefit from PolicyStreet's cost-effective insurance solutions. 

If you're behind the wheel of a Proton or Perodua, don't miss out on this chance to enjoy FREE road tax this Malaysia Day. For Malaysians who want to take advantage of this promotion but don't need to renew their car insurance just yet, stay tuned for the Cheapest Road Tax in Town available from 14 September onwards. Show your Malaysian pride and grab your free road tax from PolicyStreet today!

For the complete media kit with visual assets and spokespersons' photos, please click the link HERE.

About PolicyStreet

PolicyStreet is a regional full-stack insurance technology (insurtech) group of companies providing cutting-edge digital insurance solutions to businesses and consumers in Southeast Asia and Australia.

PolicyStreet works directly with over 40 life, general, and Takaful providers globally to offer a comprehensive range of products and services, which includes but is not limited to embedded insurance, customised employee benefits, financial advisory and aggregation of insurance, as well as the development of digital solutions to make insurance purposeful and simple for businesses and consumers.

As a licensed Reinsurer, General Insurer and Takaful Operator by the Labuan Financial Services Authority (LFSA), an approved Financial Adviser and Islamic Financial Adviser by Bank Negara Malaysia (BNM), and a licensee of the Australian Financial Services License by the Australian Securities and Investments Commission (ASIC), PolicyStreet is able to underwrite, customise policies, and provide unbiased advice to its clients and partners worldwide.

PolicyStreet is backed by the Malaysian sovereign wealth fund, Khazanah Nasional Berhad, and serves over 5 million customers with over US$ 10 billion in sum insured. In 2024, PolicyStreet was recognised as "Fintech of the Year" at The Asset's Triple A Digital Awards and ranked as the second-highest Malaysian company in the "High-Growth Companies in Asia Pacific 2024" list by Statista and The Financial Times.

For more information, please contact:
Sabrina Chong
Corporate Communications Manager, PolicyStreet
sabrina@policystreet.com
+6012 206 6375

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Keranamu Malaysia -- PolicyStreet Offers FREE Road Tax to All National Cars for Malaysia Day

Keranamu Malaysia -- PolicyStreet Offers FREE Road Tax to All National Cars for Malaysia Day

Recommended Articles